<html>
<head>PUBMED IDs for BART1</head>
<body bgcolor='#C5F0F2'><h1>BART1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21062812/'>microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma.</a> June 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21649547/'>miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation.</a> December 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22984081/'>Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1Î² production.</a> December 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23685147/'>EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma.</a> August 28  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23689138/'>Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.</a> September 17  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25213622/'>Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.</a> February 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26135619/'>Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.</a> April 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26375401/'>Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies.</a> May 28  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26497204/'>EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.</a> September 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27239439/'>miRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing.</a> May 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27239416/'>Expression of protocadherin gamma in skeletal muscle tissue is associated with age and muscle weakness.</a> May 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27757686/'>TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU.</a> October 21  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28416598/'>EBV MicroRNA BART16 Suppresses Type I IFN Signaling.</a> April 19  2017<br></body></html>
